NCT00032968View on ClinicalTrials.gov

Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1

PHASE3CompletedINTERVENTIONAL
Enrollment

341

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

August 31, 2002

Study Completion Date

August 31, 2002

Conditions
Heroin DependenceMorphine DependenceSubstance Withdrawal Syndrome
Interventions
DRUG

Buprenorphine/naloxone

Trial Locations (7)

10016

Bellevue, New York

11201

Addiction Research and Treatment Corp, Brooklyn

46202

Midtown Community Mental Health Center, Indianapolis

93033

Aegis Medical Systems, Inc., Oxnard

94704

Haight-Ashbury Free Clinic, Berkeley

97227

Kaiser Permanente Northwest, Division of Addiction, Portland

08854

UMDNJ - Robert Wood Johnson Medical School, Piscataway

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT00032968 - Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1 | Biotech Hunter | Biotech Hunter